Neurobiological Technologies, Inc. (NTII) Research

Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation and dissolution process, a plan that received stockholder endorsement in October 2009. In its earlier operations, the company's core focus was on the development of experimental pharmaceutical treatments for various human ailments. This firm, which was established in 1987, has its primary location in Emeryville, California.

Market snapshot

Symbol
NTII
Price
$0.00
Day change
0.00%
Market cap
$2.7K
P/E ratio
0.00x
52-week range
0.000001-0.0001
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Anthera Pharmaceuticals, Inc. (ANTH)
  • Comera Life Sciences Holdings, Inc. (CMRA)
  • Cotinga Pharmaceuticals Inc. (COTQF)
  • ForU Holdings, Inc. (FORU)
  • GlobeImmune, Inc. (GBIM)
  • OncoVista Innovative Therapies, Inc. (OVIT)
  • PhaseRx, Inc. (PZRXQ)
  • Rebus Holdings, Inc. (RBSH)

Recent insider activity

  • Firefly Value Partners, LP — P-Purchase (7737 shares) on 2010-06-07
  • Firefly Value Partners, LP — P-Purchase (12796 shares) on 2010-06-07
  • Firefly Value Partners, LP — P-Purchase (17653 shares) on 2010-05-19
  • Firefly Value Partners, LP — P-Purchase (11982 shares) on 2010-05-20
  • Firefly Value Partners, LP — P-Purchase (39940 shares) on 2010-05-21

Open Neurobiological Technologies, Inc. (NTII) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.